The study compared patient and general population samples to see if they have different preferences for assessing chemotherapy side effects. They used a survey where people chose between different assessment tools. The general population was split into two groups, with one group getting extra information about the side effects. The extra information helped the general population understand the choices better, but they still had different preferences compared to the patient sample. This means that using general population data may not always give accurate results for healthcare decisions.